126 related articles for article (PubMed ID: 38490063)
21. Understanding the Molecular Determinant of Reversible Human Monoamine Oxidase B Inhibitors Containing 2H-Chromen-2-One Core: Structure-Based and Ligand-Based Derived Three-Dimensional Quantitative Structure-Activity Relationships Predictive Models.
Mladenović M; Patsilinakos A; Pirolli A; Sabatino M; Ragno R
J Chem Inf Model; 2017 Apr; 57(4):787-814. PubMed ID: 28291352
[TBL] [Abstract][Full Text] [Related]
22. Monoamine oxidase inhibition by selected dye compounds.
de Beer F; Petzer JP; Petzer A
Chem Biol Drug Des; 2020 Mar; 95(3):355-367. PubMed ID: 31834986
[TBL] [Abstract][Full Text] [Related]
23. Fine molecular tuning at position 4 of 2H-chromen-2-one derivatives in the search of potent and selective monoamine oxidase B inhibitors.
Pisani L; Catto M; Nicolotti O; Grossi G; Di Braccio M; Soto-Otero R; Mendez-Alvarez E; Stefanachi A; Gadaleta D; Carotti A
Eur J Med Chem; 2013; 70():723-39. PubMed ID: 24231308
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of human monoamine oxidase A and B by flavonoids isolated from two Algerian medicinal plants.
Larit F; Elokely KM; Chaurasiya ND; Benyahia S; Nael MA; León F; Abu-Darwish MS; Efferth T; Wang YH; Belouahem-Abed D; Benayache S; Tekwani BL; Cutler SJ
Phytomedicine; 2018 Feb; 40():27-36. PubMed ID: 29496172
[TBL] [Abstract][Full Text] [Related]
25. Quinolinyl-thienyl chalcones as monoamine oxidase inhibitors and their in silico modeling studies.
Zaib S; Rizvi SU; Aslam S; Ahmad M; Ali Abid SM; Al-Rashida M; Iqbal J
Med Chem; 2015; 11(6):580-9. PubMed ID: 25541744
[TBL] [Abstract][Full Text] [Related]
26. Isatin-tethered halogen-containing acylhydrazone derivatives as monoamine oxidase inhibitor with neuroprotective effect.
Kumar S; Oh JM; Prabhakaran P; Awasti A; Kim H; Mathew B
Sci Rep; 2024 Jan; 14(1):1264. PubMed ID: 38218887
[TBL] [Abstract][Full Text] [Related]
27. Site-activated multi target iron chelators with acetylcholinesterase (AChE) and monoamine oxidase (MAO) inhibitory activities for Alzheimer's disease therapy.
Youdim MBH
J Neural Transm (Vienna); 2022 Jun; 129(5-6):715-721. PubMed ID: 35190910
[TBL] [Abstract][Full Text] [Related]
28. Xanthine-Dopamine Hybrid Molecules as Multitarget Drugs with Potential for the Treatment of Neurodegenerative Diseases.
Załuski M; Karcz T; Drabczyńska A; Vielmuth C; Olejarz-Maciej A; Głuch-Lutwin M; Mordyl B; Siwek A; Satała G; Müller CE; Kieć-Kononowicz K
Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509114
[TBL] [Abstract][Full Text] [Related]
29. Quinazolinone-based benzenesulfonamides with low toxicity and high affinity as monoamine oxidase-A inhibitors: Synthesis, biological evaluation and induced-fit docking studies.
Yamali C; Gul HI; Tugrak Sakarya M; Nurpelin Saglik B; Ece A; Demirel G; Nenni M; Levent S; Cihat Oner A
Bioorg Chem; 2022 Jul; 124():105822. PubMed ID: 35500503
[TBL] [Abstract][Full Text] [Related]
30. Searching for Multi-Targeting Neurotherapeutics against Alzheimer's: Discovery of Potent AChE-MAO B Inhibitors through the Decoration of the 2H-Chromen-2-one Structural Motif.
Pisani L; Farina R; Soto-Otero R; Denora N; Mangiatordi GF; Nicolotti O; Mendez-Alvarez E; Altomare CD; Catto M; Carotti A
Molecules; 2016 Mar; 21(3):362. PubMed ID: 26999091
[TBL] [Abstract][Full Text] [Related]
31. Positional scanning of natural product hispidol's ring-B: discovery of highly selective human monoamine oxidase-B inhibitor analogues downregulating neuroinflammation for management of neurodegenerative diseases.
Hassan AHE; Kim HJ; Gee MS; Park JH; Jeon HR; Lee CJ; Choi Y; Moon S; Lee D; Lee JK; Park KD; Lee YS
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):768-780. PubMed ID: 35196956
[TBL] [Abstract][Full Text] [Related]
32. Selected chromone derivatives as inhibitors of monoamine oxidase.
Legoabe LJ; Petzer A; Petzer JP
Bioorg Med Chem Lett; 2012 Sep; 22(17):5480-4. PubMed ID: 22850212
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and Evaluation of 2-benzylidene-1-tetralone Derivatives for Monoamine Oxidase Inhibitory Activity.
Amakali KT; Legoabe LJ; Petzer A; Petzer JP
Cent Nerv Syst Agents Med Chem; 2018; 18(2):136-149. PubMed ID: 29714148
[TBL] [Abstract][Full Text] [Related]
34. Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases.
Youdim MB; Fridkin M; Zheng H
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1455-71. PubMed ID: 15480846
[TBL] [Abstract][Full Text] [Related]
35. Phenothiazine, anthraquinone and related tricyclic derivatives as inhibitors of monoamine oxidase.
Lefin R; Petzer A; Petzer JP
Bioorg Med Chem; 2022 Jan; 54():116558. PubMed ID: 34915314
[TBL] [Abstract][Full Text] [Related]
36. Multi-targeting aurones with monoamine oxidase and amyloid-beta inhibitory activities: Structure-activity relationship and translating multi-potency to neuroprotection.
Liew KF; Lee EH; Chan KL; Lee CY
Biomed Pharmacother; 2019 Feb; 110():118-128. PubMed ID: 30466001
[TBL] [Abstract][Full Text] [Related]
37. Pyrimido[1,2-b]indazole derivatives: Selective inhibitors of human monoamine oxidase B with neuroprotective activity.
Jismy B; El Qami A; Pišlar A; Frlan R; Kos J; Gobec S; Knez D; Abarbri M
Eur J Med Chem; 2021 Jan; 209():112911. PubMed ID: 33071056
[TBL] [Abstract][Full Text] [Related]
38. Multitarget Biological Profiling of New Naphthoquinone and Anthraquinone-Based Derivatives for the Treatment of Alzheimer's Disease.
Campora M; Canale C; Gatta E; Tasso B; Laurini E; Relini A; Pricl S; Catto M; Tonelli M
ACS Chem Neurosci; 2021 Feb; 12(3):447-461. PubMed ID: 33428389
[TBL] [Abstract][Full Text] [Related]
39. Dual Inhibitors of Brain Carbonic Anhydrases and Monoamine Oxidase-B Efficiently Protect against Amyloid-β-Induced Neuronal Toxicity, Oxidative Stress, and Mitochondrial Dysfunction.
Giovannuzzi S; Chavarria D; Provensi G; Leri M; Bucciantini M; Carradori S; Bonardi A; Gratteri P; Borges F; Nocentini A; Supuran CT
J Med Chem; 2024 Mar; 67(5):4170-4193. PubMed ID: 38436571
[TBL] [Abstract][Full Text] [Related]
40. Investigating alkyl nitrates as nitric oxide releasing precursors of multitarget acetylcholinesterase-monoamine oxidase B inhibitors.
Pisani L; Iacobazzi RM; Catto M; Rullo M; Farina R; Denora N; Cellamare S; Altomare CD
Eur J Med Chem; 2019 Jan; 161():292-309. PubMed ID: 30366255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
